Study group 2 (n=250) | Control group (n=46) | P | ||
---|---|---|---|---|
LS 12.5-25 kPa (100) | LS >25 kPa (150) | |||
Age | 43.9 ± 2.5 | 45.9 ± 3.2 | 47.9 ± 2.9 | 0.001 |
M/F | 68/32 | 117/33 | 30/16 | 0.141 |
ALT IU/L | 63± 9.9 | 65.2± 12.4 | 63.1± 13.9 | 0.015 |
AST IU/L | 64.9 ± 11.5 | 69.5 ± 7.46 | 54.1 ± 10.4 | 0.0001 |
Albumin (gm/dl) | 3.63 ± 0.21 | 3.07± 0.31 | 4.26 ± 0.39 | 0.0001 |
γ- globulin (gm/dl) | 3.76±0.21 | 4.23±0.26 | 3.33±0.34 | 0.0001 |
Total bilirubin (mg/dl) | 1.18 ± 0.19 | 1.49 ± 0.25 | 0.98 ± 0.18 | 0.0001 |
Platelet count( cell/ul) | 92.5 ± 11.9 | 78.9± 10.3 | 161.2 ± 13.5 | 0.0001 |
PDW/MPV | 2.7 ± 0.44 | 3.67±0.51 | 1.7±0.35 | 0.0001 |
PC% | 61 ± 5.7 | 52.4 ± 2.8 | 76.3 ± 6.54 | 0.0001 |
CTP | 6 | 6 | 5 | - |
Sodium | 140.5 ±2.5 | 134.6±4.8 | 140 ±3.9 | 0.001 |
Ammonia (ug/dl) | 78.2±20.7 | 104±13.6 | 43.9±9.8 | 0.0001 |
Creatinine (mg/dl) | 0.99±0.25 | 1.2±0.22 | 0.82±0.42 | 0.002 |
MELD | 12.9 ±2 | 17.9±3.4 | 7.67±0.85 | 0.0001 |
LSM by fibroscan (kPa) | 20.2 ± 2.2 | 29.8±2.7 | 8.43±0.89 | 0.0001 |
Radiological Signs | ||||
- liver volume (ml) | 614.8 ± 64.7 | 554 ± 90.7 | 1265.3 ± 86.2 | 0.0001 |
Complications (n=129) | 52(40.3%) | 77 (59.7%) | 0 | 0.00001 |
-Hepatic decompensation (122) | 52 | 70 | - | 0.0001 |
-upper GIT bleeding (5) | - | 5 | - | 0.0001 |
-cardiomyopathy (2) | - | 2 | - | 0.0001 |